Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP627043.RA2EERC2EuTrP50D7e1DRdFNHQoNmyAcZgASmdXyqeOLc130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627043.RA2EERC2EuTrP50D7e1DRdFNHQoNmyAcZgASmdXyqeOLc130_provenance.
• NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_provenance.
• NP592735.RA60V1T6BIsDu0JVz3ZkCZWeEMu7pvrScrBZcCLz76_PE130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592735.RA60V1T6BIsDu0JVz3ZkCZWeEMu7pvrScrBZcCLz76_PE130_provenance.
• NP803129.RAyUp_-D1rt_pgET63kgPSbj8g4onF19uJoJtNo4mPGlI130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803129.RAyUp_-D1rt_pgET63kgPSbj8g4onF19uJoJtNo4mPGlI130_provenance.
• NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_provenance.
• NP846841.RAPyKEiudvFKURvCMznED3wCY-AtJPLy7dqXAa-eutipE130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846841.RAPyKEiudvFKURvCMznED3wCY-AtJPLy7dqXAa-eutipE130_provenance.
• NP863610.RAT1EPYjwLE3_nljYKGgw0-X0NK-eSyXV5pYiRQIzx2ko130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863610.RAT1EPYjwLE3_nljYKGgw0-X0NK-eSyXV5pYiRQIzx2ko130_provenance.
• NP856641.RA9DhdIErjJKmSRNRimBEgpczO_E5at82INn4bL3XN0f4130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856641.RA9DhdIErjJKmSRNRimBEgpczO_E5at82INn4bL3XN0f4130_provenance.
• NP859492.RA_Bnwvmn9wMOoyIeoDa54R4Qv8pRrtaZK34T56pHFPE0130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859492.RA_Bnwvmn9wMOoyIeoDa54R4Qv8pRrtaZK34T56pHFPE0130_provenance.
• NP367441.RA14h1oaOFm_LnvnhhwlJeHg2IJIwoCxemYdmC8wPd7po130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367441.RA14h1oaOFm_LnvnhhwlJeHg2IJIwoCxemYdmC8wPd7po130_provenance.
• NP367442.RA3n_x10Pdf7_WcR7vNF2gAbRNOBRlscZ68f-qS2Qy5UU130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367442.RA3n_x10Pdf7_WcR7vNF2gAbRNOBRlscZ68f-qS2Qy5UU130_provenance.
• NP367444.RAwLYtAwAhIctW2xRS5nnHilD2tDPFfc8L9Mk5DNVN2II130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367444.RAwLYtAwAhIctW2xRS5nnHilD2tDPFfc8L9Mk5DNVN2II130_provenance.
• NP367445.RA3VNIB9luTwKCQBXDQSmaaECywfyznBG3BDYhbZzqF34130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367445.RA3VNIB9luTwKCQBXDQSmaaECywfyznBG3BDYhbZzqF34130_provenance.
• NP367446.RAzrOPZOksy7bm-DJWY2K3n-cGIsYy_zLFoVQQs_yuMsg130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367446.RAzrOPZOksy7bm-DJWY2K3n-cGIsYy_zLFoVQQs_yuMsg130_provenance.
• NP367439.RAGUb9t-8Adh8paYAupLoCqmT3jzhh0WgFcb7UPUuFLbI130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367439.RAGUb9t-8Adh8paYAupLoCqmT3jzhh0WgFcb7UPUuFLbI130_provenance.
• NP367443.RANYoR26NIYwjbeIBi0dvEImZOqmMSq4EVl6JpqXhE1vI130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367443.RANYoR26NIYwjbeIBi0dvEImZOqmMSq4EVl6JpqXhE1vI130_provenance.
• NP367437.RAvv35te5mKTu6xF7yyv3MQK0UELUjyAYe_b8eSykkuio130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367437.RAvv35te5mKTu6xF7yyv3MQK0UELUjyAYe_b8eSykkuio130_provenance.
• NP367438.RAt5h7kV-cKVyGF4H06I2MDGtY6OfFwoMJ1G3btcPpMNM130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367438.RAt5h7kV-cKVyGF4H06I2MDGtY6OfFwoMJ1G3btcPpMNM130_provenance.
• NP367440.RAu51KjhGF2dI1_BKBfuXlnRnFtAR8052srrfd7CBgzxE130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367440.RAu51KjhGF2dI1_BKBfuXlnRnFtAR8052srrfd7CBgzxE130_provenance.
• NP289731.RAu3hSPIwjhAtNrbt3-0DJqLYgYFWldCqiHhjBmAwEjmQ130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289731.RAu3hSPIwjhAtNrbt3-0DJqLYgYFWldCqiHhjBmAwEjmQ130_provenance.